Markers of Autoimmune Rheumatic Diseases
- 18 September 2024
- book chapter
- Published by Springer Nature
- p. 387-426
Abstract
No abstract availableKeywords
This publication has 199 references indexed in Scilit:
- Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical CareACR Open Rheumatology, 2020
- Anti–RNPC‐3 (U11/U12) Antibodies in Systemic Sclerosis in Patients With Moderate‐to‐Severe Gastrointestinal DysmotilityArthritis Care & Research, 2019
- Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle InvolvementArthritis Care & Research, 2014
- Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosisArthritis & Rheumatism, 2008
- Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: Mortality risk and quality of life early in the course of diseaseArthritis Care & Research, 2008
- A comparison between anti‐Th/To– and anticentromere antibody–positive systemic sclerosis patients with limited cutaneous involvementArthritis & Rheumatism, 2003
- Association of autoantibodies against the phosphatidylserine–prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulantArthritis & Rheumatism, 2000
- Interferon-? does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Results of a randomized, double-blind, placebo-controlled trialArthritis & Rheumatism, 1999
- Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infectionArthritis & Rheumatism, 1997
- Autoantibody to th ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosisArthritis & Rheumatism, 1990